Caveolin-1 expression in pleomorphic carcinoma correlated with poor prognosis
TMCnet
TMC Launches New Sites :: Cable 4G Wireless Evolution  |  Satellite  |  Green Tech  | IT | IVR |  ITEXPO East begins in:   REGISTER NOW!
  INDUSTRIES
  PUBLICATIONS
  FREE RESOURCES
  INTERNATIONAL
  EVENTS
  ABOUT TMC
  COMMUNITIES
E-mail this page to a friend Order reprints online Print this page Bookmark this page Free magazines Free newsletters RSS-XML alerts
TMCnews
[February 23, 2006]

Caveolin-1 expression in pleomorphic carcinoma correlated with poor prognosis

(Science Letter Via Thomson Dialog NewsEdge)
Caveolin-1 expression in pleomorphic carcinoma of the lung was associated with a poor prognosis.

According to a study from South Korea, "Caveolin-l is implicated in the oncogenic transformation of cells as a tumor suppressor in several human carcinomas, the expression of caveolin-1 has been reported to be correlated with prognosis. The present study was designed to clarify the clinicopathological significance of caveolin-1 expression in pleomorphic carcinoma of the lung (PCL). Twenty-one cases of PCL were immunohistochemically evaluated for caveolin-1 expression."



"Caveolin-1 was expressed in 18 out of 21 cases. Patients with high caveolin-1 expression in PCL showed lower disease-free and overall survival rates than those with low caveolin-1 expression," explained K.C. Moon and colleagues, Seoul National University.

The researchers concluded, "However, the expression level of caveolin-1 in PCL was not significantly correlated with age, stage, pT category, pN category, or tumor size. These results suggest that the overexpression of caveolin-1 is significantly correlated with a poor prognosis in patients with PCL and that it is marker for predicting prognosis in PCL."



Moon and colleagues published their study in Anticancer Research (Expression of caveolin-1 in pleomorphic carcinoma of the lung is correlated with a poor prognosis. Anticancer Res, 2005;25(6C):4631-4637).

For more information, contact D.H. Chung, Seoul National University, College Med, Dept. Pathology, 28 Chongnogu, Seoul 110799, South Korea.

Publisher contact information for the journal Anticancer Research is: International Institute Anticancer Research, Editorial Office 1st km Kapandritiou-Kalamou Rd. Kapandriti, PO Box 22, Athens 19014, Greece.

Keywords: Seoul, South Korea, Lung Cancer, Lung Carcinoma, Oncology, Pleomorphic Cancer, Pleomorphic Carcinoma, Prognosis, Prognostics, Cancer Therapy, Tumor Suppression, Tumors, Caveolin-1.

This article was prepared by Science Letter editors from staff and other reports. Copyright 2006, Science Letter via NewsRx.com.

[ Back To TMCnet.com's Homepage ]


Discussions:
Be the first to post a comment on this page!
 
By  
TMCnet
Featured White Papers
Top Stories
Related VoIP News

Today @ TMC
Upcoming Events
19th INTERNET TELEPHONY Conference & EXPO East
February 2-4, 2009 — Miami Beach Convention Center, Miami, FL
Digium Asterisk World Conference
February 2-4, 2009 — Miami Beach Convention Center, Miami, FL
4G Wireless Evolution Conference
February 2-4, 2009 — Miami Beach Convention Center, Miami, FL
6th Annual Communications Developer Conference
February 2-4, 2009 — Miami Beach Convention Center, Miami, FL
20th INTERNET TELEPHONY Conference & EXPO West
October 27-29, 2009 — Los Angeles Convention Center, Los Angeles, CA
Subscribe FREE to all of TMC's monthly magazines. Click here now.